Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa

[1]  L. Frenzel,et al.  Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia/lymphoma , 2020, Retrovirology.

[2]  H. Ochiai,et al.  Clinical features and treatment outcomes of opportunistic infections among human T-lymphotrophic virus type 1 (HTLV-1) carriers and patients with adult T-cell leukemia-lymphoma (ATL) at a single institution from 2006 to 2016 , 2019, Journal of clinical and experimental hematopathology : JCEH.

[3]  T. Waldmann,et al.  Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  G. Barber,et al.  Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States. , 2018, Blood advances.

[5]  L. Trentin,et al.  Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia , 2017, Hematological oncology.

[6]  F. Dromer,et al.  The risk and clinical outcome of candidemia depending on underlying malignancy , 2017, Intensive Care Medicine.

[7]  V. Miller,et al.  Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  H. Einsele,et al.  ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. , 2016, The Journal of antimicrobial chemotherapy.

[9]  T. Miyamoto,et al.  Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma , 2016, Bone Marrow Transplantation.

[10]  S. Hanada,et al.  Treatment and survival among 1594 patients with ATL. , 2015, Blood.

[11]  K. Thursky,et al.  Epidemiology of invasive fungal disease in lymphoproliferative disorders , 2015, Haematologica.

[12]  R. Ueda,et al.  Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study , 2015, British journal of haematology.

[13]  F. Dromer,et al.  Population-Based Analysis of Invasive Fungal Infections, France, 2001–2010 , 2014, Emerging infectious diseases.

[14]  A. Gessain,et al.  Epidemiological Aspects and World Distribution of HTLV-1 Infection , 2012, Front. Microbio..

[15]  A. Bazarbachi,et al.  Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment , 2012, Leukemia research and treatment.

[16]  B. Lebeau,et al.  Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007). , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  A. Bazarbachi,et al.  Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  K. Ohshima,et al.  Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  K. Yamaguchi,et al.  Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  R. Ueda,et al.  VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  A. Bazarbachi,et al.  A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma. , 2002, The hematology journal : the official journal of the European Haematology Association.

[24]  H. Einsele,et al.  Definitions of infectious diseases and complications after stem cell transplant , 2002 .

[25]  M. Tomonaga,et al.  A new G‐CSF‐supported combination chemotherapy, LSG15, for adult T‐cell leukaemia‐lymphoma: Japan Clinical Oncology Group Study 9303 , 2001, British journal of haematology.

[26]  T. Waldmann,et al.  The Combination of Zidovudine and Interferon AIpha-2B in the Treatment of Adult T-Cell Leukemia/Lymphoma , 2001, Leukemia & lymphoma.

[27]  M. Kaplan,et al.  Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. , 1995, The New England journal of medicine.

[28]  E. Macintyre,et al.  Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa , 1995 .

[29]  T. Waldmann,et al.  Infectious complications and immunodeficiency in patients with human T‐cell lymphotropic virus I‐associated adult T‐cell leukemia/lymphoma , 1995, Cancer.

[30]  M. Tomonaga,et al.  [Infectious complications in patients with adult T-cell leukemia]. , 1992, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[31]  M. Shimoyama,et al.  Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma , 1991, British journal of haematology.

[32]  J. Goedert,et al.  Modelling the risk of adult T‐cell leukemia/lymphoma in persons infected with human T‐lymphotropic virus type I , 1989, International journal of cancer.

[33]  K. Tamura.  [Treatment of adult T-cell leukemia]. , 1986, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[34]  W. Blattner,et al.  Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. , 1983, The New England journal of medicine.